Evidence map›Paper›PMID 39948309›Full record

ArticleAnnals of surgical oncology2025

Decreasing Use of CT in Favor of Colonoscopy: A Retrospective Analysis of Post-Operative Imaging in Nonmetastatic dMMR/MSI-H Sporadic Colorectal Cancer.

Si-Yuan Mi, Yi-Jun Liao, Da Kang, Xin Tang, Gong Chen, Zhi-Zhong Pan, Jianhua Zhan, Rong-Xin Zhang

Abstract read
PubMed Publisher
In one paragraph

Article in Annals of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Si-Yuan Mi *State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Yi-Jun Liao *State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Da Kang *State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Xin TangState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Gong ChenState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Zhi-Zhong PanState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Jianhua Zhan *State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China. zhanjh@sysucc.org.cn.
Rong-Xin Zhang *State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China. zhangrx@sysucc.org.cn.

Funding

Basic and Applied Basic Research Foundation of Guangdong Province 2023A1515010243Chinese Society of Clinical Oncology Foundation Y-HR2018-319Chinese Society of Clinical Oncology Foundation Y-JS2019-009Chinese Society of Clinical Oncology Foundation Y-L2017-002National Natural Science Foundation of China 82473398Sun Yat-sen University Basic Research Fund 19ykpy180the open research funds from the Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People's Hospital 202011-103the open research funds from the Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People's Hospital 202301-314
6 · The paper itself

Abstract

backgroundThere is no significant difference in postoperative follow-up imaging examinations for varying mismatch repair (MMR)/microsatellite instability (MSI) statuses for sporadic colorectal cancer while facing different prognoses.

methodsWe conducted a retrospective study, using Kaplan-Meier curve to compare survival/progression status by varying imaging examination and frequency, using Cox regression to analyze tumor characteristic impact on survival, and monitoring polyp detection time in each colonoscopy screening.

resultsA total of 282 deficient MMR (dMMR)/MSI-high (MSI-H) patients were included. After a 7 year follow-up, all patients-including 143 examined by CT and colonoscopy, 86 singularly examined (CT/colonoscopy/ultrasound), and 53 received no imaging examination-demonstrated a favorable overall survival (87.97%, 95% CI 75.99-89.19) and disease-free survival (81.92%, 95% CI 70.38-89.30), which had no significant difference between imaging methods. Cox regression proved that different imaging methods had no influence on the prognosis. Stage III patients experienced a deterioration in disease-free survival but not differed between varying imaging methods. Different CT follow-up interval exhibited no difference in survival and progression. Polyps were detected in 39.75% (64/161) of patients during follow-up; 32.81% (21/64) were detected in colonoscopy conducted 0-6 months after surgery, reaching the highest. For multiple polyps, the median of detection interval was 13-24 months (first and second polyps), 7-12 months (second and third polyps).

conclusionsFor nonmetastatic dMMR/MSI-H sporadic colorectal cancer patients, less CT scans (interval > 1 year) are tolerable because of good prognosis, whereas more colonoscopy screenings (0-6 months after surgery first year; 13-24 months after first polyps detection; 7-12 months after second polyps detection) is considerable.

Indexed as

ColonoscopyColorectal NeoplasmsDNA Mismatch RepairMicrosatellite InstabilityTomography, X-Ray ComputedAdultAgedFemaleFollow-Up StudiesHumansMaleMiddle AgedPrognosisRetrospective StudiesSurvival RateFollow upImagingMicrosatellite instabilityMismatch repairPost operativeSporadic colorectal cancer

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.